Phase II Clinical Study of BC-3781, a Pleuromutilin Antibiotic, in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections
PRINCE, W. T, LVEZIC-SCHOENFELD, Z, LELL, C, TACK, K. J, NOVAK, R, OBERMAYR, F, TALBOT, G. H
Published in Antimicrobial Agents and Chemotherapy (01.05.2013)
Published in Antimicrobial Agents and Chemotherapy (01.05.2013)
Get full text
Journal Article
Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infection
Gerding, D N, Hecht, D W, Louie, T, Nord, C E, Talbot, G H, Cornely, O A, Buitrago, M, Best, E, Sambol, S, Osmolski, J R, Kracker, H, Locher, H H, Charef, P, Wilcox, M
Published in Journal of antimicrobial chemotherapy (01.01.2016)
Published in Journal of antimicrobial chemotherapy (01.01.2016)
Get full text
Journal Article
10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America
Boucher, Helen W, Talbot, George H, Benjamin, Jr, Daniel K, Bradley, John, Guidos, Robert J, Jones, Ronald N, Murray, Barbara E, Bonomo, Robert A, Gilbert, David
Published in Clinical infectious diseases (15.06.2013)
Published in Clinical infectious diseases (15.06.2013)
Get full text
Journal Article
The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium
MOELLERING, R. C, LINDEN, P. K, REINHARDT, J, BLUMBERG, E. A, BOMPART, F, TALBOT, G. H
Published in Journal of antimicrobial chemotherapy (01.08.1999)
Published in Journal of antimicrobial chemotherapy (01.08.1999)
Get full text
Journal Article
Safety and tolerability of quinupristin/dalfopristin: administration guidelines
Rubinstein, E., Prokocimer, P., Talbot, G. H.
Published in Journal of antimicrobial chemotherapy (01.09.1999)
Published in Journal of antimicrobial chemotherapy (01.09.1999)
Get full text
Journal Article
Characterization of isolates associated with emerging resistance to quinupristin/dalfopristin (Synercid®) during a worldwide clinical program
Dowzicky, M, Talbot, G.H, Feger, C, Prokocimer, P, Etienne, J, Leclercq, R
Published in Diagnostic microbiology and infectious disease (01.05.2000)
Published in Diagnostic microbiology and infectious disease (01.05.2000)
Get full text
Journal Article
Characterization of vancomycin-resistant Enterococcus faecium isolates from the united states and their susceptibility in vitro to dalfopristin-quinupristin
ELIOPOULOS, G. M, WENNERSTEN, C. B, MOELLERING, R. C, GOLD, H. S, SCHÜLIN, T, SOULI, M, FARRIS, M. G, CERWINKA, S, NADLER, H. L, DOWZICKY, M, TALBOT, G. H
Published in Antimicrobial agents and chemotherapy (01.05.1998)
Published in Antimicrobial agents and chemotherapy (01.05.1998)
Get full text
Journal Article
Risk factors for nosocomial candidemia: A case-control study in adults without leukemia
Bross, James, Talbot, George H., Maislin, Greg, Hurwitz, Shelley, Strom, Brian L.
Published in The American journal of medicine (01.12.1989)
Published in The American journal of medicine (01.12.1989)
Get full text
Journal Article
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
Talbot, George H., Bradley, John, Edwards, John E., Gilbert, David, Scheld, Michael, Bartlett, John G.
Published in Clinical infectious diseases (01.03.2006)
Published in Clinical infectious diseases (01.03.2006)
Get full text
Journal Article
What is the cost of nephrotoxicity associated with aminoglycosides?
Eisenberg, J M, Koffer, H, Glick, H A, Connell, M L, Loss, L E, Talbot, G H, Shusterman, N H, Strom, B L
Published in Annals of internal medicine (01.12.1987)
Published in Annals of internal medicine (01.12.1987)
Get more information
Journal Article
Safety profile of sparfloxacin, a new fluoroquinolone antibiotic
Lipsky, Benjamin A., Dorr, Mary Beth, Magner, D.J., Talbot, George H.
Published in Clinical therapeutics (1999)
Published in Clinical therapeutics (1999)
Get full text
Journal Article
Cdad-Daysyms™: A New Patient-Reported Outcome Tool For Clostridium Difficile -Associated Diarrhoea
Kleinman, L, Talbot, G.H, Schüler, R, Broderick, K, Revicki, D, Nord, C.E
Published in Value in health (01.11.2014)
Published in Value in health (01.11.2014)
Get full text
Journal Article
The cardiac pharmacodynamics of therapeutic doses of sparfloxacin
Morganroth, Joel, Hunt, Thomas, Dorr, Mary Beth, Magner, David, Talbot, George H.
Published in Clinical therapeutics (01.07.1999)
Published in Clinical therapeutics (01.07.1999)
Get full text
Journal Article